Article
Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
Leukemia research - 1 Nov 1998
Garicochea B, Giorgi R, Odone V F, Dorlhiac-Llacer P E, Bendit I
Abstract excerpt
RAS mutations can be detected in a variable number of patients with myeloproliferative disorders such as myelodysplastic syndromes and acute myeloid leukemia, but are rare events in chronic myelogenous leukemia in chronic phase. However, there is good evidence supporting the involvement of RAS signalling pathway in CML and this could be due to alterations in RAS activity regulatory proteins. The neurofibromatosis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
